The invention provides compounds of general formula (I) wherein m, n, Z1, Z2, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined in the specification, process for their preparation, pharmaceutical compositions containing them and their use in therapy.

 
Web www.patentalert.com

< Protective antigen of Epstein Barr Virus

< ERAAP modulators regulate immune responses

> Compositions that bind antiterminator RNA and assay for screening such compositions

> Human p21-activated kinase 5 polypeptide
~ 00242